DefenCath® (taurolidine and heparin) catheter lock solution is indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis (HD) through a central venous catheter (CVC). This drug is indicated for use in a limited and specific population of patients.

Contact Us

CorMedix Inc.

300 Connell Drive
Suite 4200
Berkeley Heights, NJ 07922
TEL +1 908-517-9500
FAX +1 908-375-8272

Medical Information:
Email: cormedix@tmacmail.com
Phone: 844-424-6345

Formulary Information Requests:
Email: cormedix@tmacmail.com
Phone: 844-424-6345

Product Quality Complaints:
Email: cormedix@tmacmail.com
Phone: 844-424-6345

For Investors & Media:

Dan Ferry
LifeSci Advisors, LLC

daniel@lifesciadvisors.com

617-430-7576

Careers
Join our team.